Ulysses Smith

The outlook and analysis of CytomX Therapeutics Inc (CTMX)’s stock
At the time of writing, CytomX Therapeutics Inc [CTMX] stock is trading at $3.3, up 0.61%. Until recently, the best ...

Gildan Activewear Inc (GIL) is expected to grow earnings and revenues in the years ahead
At the time of writing, Gildan Activewear Inc [GIL] stock is trading at $60.96, up 1.94%. It is a good ...

Analysts’ expectations for Ermenegildo Zegna N.V (ZGN) stock: $11.5 price target in 12 months
At the time of writing, Ermenegildo Zegna N.V [ZGN] stock is trading at $10.37, up 2.27%. One of the good ...

Leidos Holdings Inc (LDOS) stock poised to deliver a potential drop of -4.0%
At the time of writing, Leidos Holdings Inc [LDOS] stock is trading at $195.58, up 1.39%. In order to assess ...

Neogenomics Inc (NEO) stock expected to gain 4.4% in the coming months
At the time of writing, Neogenomics Inc [NEO] stock is trading at $9.1, up 1.34%. An important factor to consider ...

Key Takeaways from Exact Sciences Corp (EXAS)’s Recent Sales and Margin Figures
At the time of writing, Exact Sciences Corp [EXAS] stock is trading at $56.72, up 0.94%. Until recently, the best ...

Growth and Margin Analysis of Acrivon Therapeutics Inc (ACRV)’s Recent Quarter Sales
At the time of writing, Acrivon Therapeutics Inc [ACRV] stock is trading at $1.91, up 2.69%. It is a good ...

Is Lineage Inc (LINE) Stock a Good Buy for Short-term Investors?
At the time of writing, Lineage Inc [LINE] stock is trading at $41.46, up 3.57%. One of the good ways ...

Is Twist Bioscience Corp (TWST) Holding Up Well Over a Long-Time Horizon?
At the time of writing, Twist Bioscience Corp [TWST] stock is trading at $31.07, up 1.27%. An important factor to ...